We have French content available. View French site.

Snap Chart

A Big Bounceback for Healthcare Private Equity

The industry logged records for the number of deals and disclosed value in 2021, and competition for deals should intensify.

Snap Chart

A Big Bounceback for Healthcare Private Equity

In the second year of Covid-19, healthcare private equity activity showed remarkable resilience to the widespread disruption, posting a record year for both deal volume and disclosed value. This stemmed partly from a pandemic-induced backlog of parked deals, as well as the revival of megadeals. Competition looks set to intensify, following the record number of healthcare-focused funds initiated in 2021 and total capital raised. Major trends include these:

  • the consumerization of care;
  • digital solutions that improve operational efficiency;
  • a willingness to take on drug development risk;
  • large transactions in European biopharma and life sciences tools; and
  • an even higher baseline for deals in Asia-Pacific.


Read the Related Report

Healthcare Private Equity Market 2021: The Year in Review

The industry roared back after a pandemic-induced lull in 2020.

Mots clés

Vous souhaitez continuer cette conversation ?

Nous aidons des dirigeants du monde entier à matérialiser des impacts et des résultats pérennes et créateurs de valeur dans leurs organisations.